Attovia Therapeutics Inc. (ATTO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Attovia Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Attovia Therapeutics Inc. (ATTO) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $685M. It trades at $15.80, up 5.33% today. Its overall quality score is 46 out of 100, ranked against the whole US market. 4 analysts' average target of $39.75 implies +151.6% from today's price. Kronos AI's 30-day forecast is +17.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $39.75 |
| Low – high | $30.00 – $45.00 |
| Analysts | 4 |
| Upside to average | +151.6% |
Kronos AI 30-day forecast
| Expected close | $17.61 (+17.4%) |
| Likely range | +13.0% … +29.8% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 30 |
| Solvency | 64 |
| Growth | 44 |
| Overall | 46 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator